Investor Overview

VYNE Therapeutics® is a biopharmaceutical company.

Committed to addressing unmet needs and providing new options for patients with immuno-inflammatory conditions.

NASDAQ-GS: VYNE

1.89

Oct. 04, 2024 16:00:00
  • Change 0 (0%)
  • Volume 11,142
  • Today's Open 1.86
  • Previous Close 1.89
  • Today's High 2
  • Today's Low 1.86
  • 52 Week High 4.481
  • 52 Week Low 1.57